The alternatives
BeyondMD scores 61/100 (grade C, ranked #349) on The Verdict Score. Here are the GLP-1 providers we'd weigh against it, scored on the same six-factor rubric. Partners we work with carry a small, fixed edge in where they are listed; the scores themselves are not adjusted.
This shortlist uses nearby positions in our published ranking, with our featured partner shown first. It compares program terms and features; your clinician must assess treatment suitability.
Published by The GLP-1 Verdict
Check dates vary by provider.
The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
CoreAge Rx scores 94/100 to BeyondMD's 61, and our BeyondMD vs CoreAge Rx comparison sets the two out factor by factor.
Publishes a real 36-state list, then prices tirzepatide only by the quarter and carries another company's copy inside its own legal pages.
VevaRX matches BeyondMD at 61/100; our VevaRX review in full has the pricing conditions and the caveats in detail.
Eve is a women's-health-focused GLP-1 telehealth platform — distinctive positioning in a largely gender-neutral market — offering both compounded semaglutide and tirzepatide (including an oral sublingual…
Eve matches BeyondMD at 61/100; our Eve review in full has the pricing conditions and the caveats in detail.
Publishes an unusually complete price grid covering compounded injections, oral tablets and brand Ozempic and Zepbound, but charges you before any clinician has reviewed your intake.
Luvo Health scores 59/100 to BeyondMD's 61; the full Luvo Health review has the pricing conditions and the caveats in detail.
Fitstry is the GLP-1 weight-loss program of Weightstry, LLC, a LegitScript-certified, cash-pay telehealth practice focused on women 40+.
Fitstry matches BeyondMD at 61/100; the full Fitstry review has the pricing conditions and the caveats in detail.
Spry is a weight-loss and anti-aging telehealth platform pairing compounded semaglutide ($199/mo) and tirzepatide ($299/mo) with three longevity peptides — BPC-157, NAD+, and sermorelin ($249–$299/mo).
Spry scores 62/100 to BeyondMD's 61; our full write-up on Spry has the pricing conditions and the caveats in detail.
FormBlends is a US direct-to-consumer brand selling compounded GLP-1 weight-loss medication — compounded semaglutide from $99 and compounded tirzepatide from $349 — dispensed by a licensed 503A pharmacy and…
FormBlends matches BeyondMD at 61/100; our FormBlends review in full has the pricing conditions and the caveats in detail.
See the complete rankings, the alternatives to every provider, A to Z, or head to the comparison hub.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Not medical advice; see our disclosure.